Importantly, there was a strong trend suggesting an interaction between MRD status and benefit from allo-HSCT in first remission.
← all excerpts
Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia.
1
—
—
Importantly, there was a strong trend suggesting an interaction between MRD status and benefit from allo-HSCT in first remission.